What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001527166
Total reported value
$10.0B
$10.0B
20 檔
49.8%
The Q2 2025 SEC filing reveals that Carlyle Group Inc. held a total portfolio value of $10.0B, covering 20 public equity positions.
In Q2 2025, Carlyle Group Inc. adopted a defensive or profit-taking posture, trimming 2 positions and completely liquidating 5 holdings to manage risk exposure.
In terms of portfolio concentration, the top 5 core holdings (including SARO, SLNOEUR, PHAT) accounted for 49.8% of total reported equity market value during Q2 2025.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SARO | Standardaero Inc | Stock-Other | 96.03% | +4.72% | +13.64% | |
| 2 | SLNOEUR | Soleno Therapeutics Inc | Stock-Other | 1.43% | — | — | |
| 3 | PHAT | Phathom Pharmaceuticals Inc | Stock-Other | 0.67% | +0.01% | — | |
| 4 | PONY | Pony Ai Inc | Stock-Other | 0.62% | -0.05% | — | |
| 5 | INVH | Invitation Homes Inc | Stock-Real Estate | 0.31% | +0.04% | — | |
| 6 | GETY | Getty Images Holdings Inc | Stock-Other | 0.21% | — | — | |
| 7 | CUBE | Cubesmart | Stock-Real Estate | 0.19% | -0.08% | EXIT | |
| 8 | JSPR | Jasper Therapeutics Inc | Stock-Other | 0.12% | -0.01% | — | |
| 9 | EM | Smart Share Global LTD - Adr | Stock-Other | 0.09% | — | -12.73% | |
| 10 | ✓ | Hillevax Inc | Stock-Other | 0.07% | — | — | |
| 11 | FWRD | Forward Air CORP | Stock-Other | 0.06% | -0.01% | — | |
| 12 | SPWR | Sunpower Inc | Stock-Other | 0.06% | +0.01% | -20.01% | |
| 13 | XCUR | Exicure Inc | Stock-Other | 0.04% | — | EXIT | |
| 14 | TORCEUR | Adicet Bio Inc | Stock-Other | 0.04% | — | — | |
| 15 | QTTB | Q32 Bio Inc | Stock-Other | 0.03% | -0.06% | — | |
| 16 | DNUT | Krispy Kreme Inc | Stock-Other | 0.02% | — | — | |
| 17 | NABL | N-able Inc | Stock-Other | 0.02% | — | — | |
| 18 | OKUR | Onkure Therapeutics Inc-a | Stock-Other | 0.01% | — | — | |
| 19 | HOOD | Robinhood Markets Inc - A | Stock-Financials | — | — | — | |
| 20 | ✓ | Nucana PLC | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SARO | Standardaero Inc | +1.9% | +13.64% | Add |
| 2 | PHAT | Phathom Pharmaceuticals Inc | +0.1% | — | Unchanged |
| 3 | PONY | Pony Ai Inc | +0.1% | — | Unchanged |
| 4 | FWRD | Forward Air CORP | +0.1% | NEW | New buy |
| 5 | JSPR | Jasper Therapeutics Inc | — | — | Unchanged |
| 6 | ✓ | Hillevax Inc | — | — | Unchanged |
| 7 | HOOD | Robinhood Markets Inc - A | — | NEW | New buy |
| 8 | ✓ | Nucana PLC | — | — | Unchanged |
| 9 | NABL | N-able Inc | — | — | Unchanged |
| 10 | CART | Maplebear Inc | 0% | EXIT | Sold out |
| 11 | SPRU | Spruce Power Holding Corporation | 0% | EXIT | Sold out |
| 12 | DNUT | Krispy Kreme Inc | 0% | — | Unchanged |
| 13 | OKUR | Onkure Therapeutics Inc-a | 0% | — | Unchanged |
| 14 | TORCEUR | Adicet Bio Inc | 0% | — | Unchanged |
| 15 | QTTB | Q32 Bio Inc | 0% | — | Unchanged |
| 16 | SPWR | Sunpower Inc | 0% | -20.01% | Trim |
| 17 | EM | Smart Share Global LTD - Adr | 0% | -12.73% | Trim |
| 18 | XCUR | Exicure Inc | -0.1% | — | Unchanged |
| 19 | CUBE | Cubesmart | -0.1% | — | Unchanged |
| 20 | FWRDUSD | Forward Air CORP | -0.1% | EXIT | Sold out |
| 21 | GETY | Getty Images Holdings Inc | -0.1% | — | Unchanged |
| 22 | INVH | Invitation Homes Inc | -0.1% | — | Unchanged |
| 23 | SMHI | Seacor Marine Holdings Inc | -0.2% | EXIT | Sold out |
| 24 | SLNOEUR | Soleno Therapeutics Inc | -0.2% | — | Unchanged |
| 25 | WRD | Weride Inc-adr | -1.2% | EXIT | Sold out |
According to official SEC Form 13F filings, Carlyle Group Inc. reported a total U.S. public equity portfolio value of $10.0B across 20 disclosed positions in Q2 2025.
During Q2 2025, Carlyle Group Inc.'s top holdings by market value included SARO (96.0%)、SLNOEUR (1.4%)、PHAT (0.7%). The largest single position, SARO, represented 96.0% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
FWRD
市值: $3.0M
Top Position Liquidated / Trimmed
WRD
前期市值: $46.5M
In Q2 2025, Carlyle Group Inc. made 10 total portfolio adjustments, initiating 2 new buys, adding to 1 positions, trimming 2 holdings, and fully liquidating 5 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.